Pacific Life Science Holding Ltd. (PLS) was established in early 2004 as a holding company for private ventures in the life sciences industry. Its main involvements include projects in biotechnology, medical equipment, pharmaceuticals, and health-care services in Asia - namely China, Hong Kong, Taiwan, and Japan. PLS seeks to transfer promising biotechnology from North America to the Asian market. By engaging in partnerships with North American life sciences firms, PLS is able to bypass the cost and time barriers of research & development. Using this strategy, PLS can participate in the most profitable stage of development in the life science sector with a relatively smaller investment, and with inherently lower risks.
PLS provides expertise in (1) finance assembly (2) business strategy (3) project and operational development. PLS's strong network and experience in Asia is valuable to North American life sciences firms interested in successfully establishing and/or expanding in the Asian market with lower risk and minimal time. Currently, the main business is focused on North American life sciences, however, PLS plans to fully commercialize and eventually listing in the near future. |
